NAS:HCM (Hong Kong)  
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd

$ 13.27 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
2.90
Market Cap:
$ 2.26B
Enterprise V:
$ 1.45B
Volume:
141.38K
Avg Vol (2M):
355.82K
Also Trade In:
Volume:
141.38K
Market Cap $:
2.26B
PE Ratio:
At Loss
Avg Vol (2-Month):
355.82K
Enterprise Value $:
1.45B
PB Ratio:
2.90
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

HUTCHMED (China) Ltd
NAICS : 325412
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
Description
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
Name Current Vs Industry Vs History
Cash-To-Debt 1976.56
Equity-to-Asset 0.67
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.63
Distress
Grey
Safe
Beneish M-Score -2.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.47
9-Day RSI 47.75
14-Day RSI 50.61
6-1 Month Momentum % -53.65
12-1 Month Momentum % -68.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.18
Quick Ratio 3.03
Cash Ratio 2.57
Days Inventory 113.36
Days Sales Outstanding 179.79
Days Payable 127.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.1

Financials (Next Earnings Date:2022-11-01 Est.)

HCM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:HCM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 157.362
EPS (TTM) ($) -0.7
Beta 0.93
Volatility % 58.8
14-Day RSI 50.61
14-Day ATR ($) 0.817897
20-Day SMA ($) 13.146
12-1 Month Momentum % -68.77
52-Week Range ($) 8.405 - 42.93
Shares Outstanding (Mil) 172.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HUTCHMED (China) Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More